-
In a randomized, double-blind, placebo-controlled trial, clonidine and venlafaxine both proved superior to placebo in reducing hot flashes in breast cancer patients. The study was insufficiently powered to prove superiority of one drug over the other. However, venlafaxine produced earlier reductions and it appeared clonidine had more sustained effect (i.e., at 12 weeks of treatment).
-
The authors conclude that patients with coronary stents undergoing an invasive procedure are at high risk of perioperative cardiovascular and bleeding complications, and that these are associated with a high mortality.
-
Recent retrospective studies in Europe have created concern because of an observed increased risk of cancer (hazard ratio = 1.55) in users of insulin glargine (GLAR) compared to nonusers.
-
A newly developed instrument to measure brief physical activity counseling in primary care demonstrates that physicians need to do a better job.
-
From a large cohort of women followed prospectively and with an adjunct meta-analysis of existing evaluable studies, a clearly demonstrated, nearly universal (i.e., across tumor types) incremental increase in cancer incidence was observed with advancing height.
-
Vaccination has dramatically reduced the number of cases of chickenpox, measles, polio, mumps, and pertussis treated in primary care settings. Antibiotic treatment of streptococcal pharyngitis has reduced the number of cases of rheumatic fever. As a result, there are generations of physicians who have never encountered patients with these diseases. These diseases are often relegated to the historical section of general medical textbooks. However, recent isolated outbreaks in adults as well as children have brought these diseases back into the forefront for primary care providers.
-
The authors conclude that this large observational study suggests ACEI or ARB therapy is associated with an improved survival and a lower risk of cardiovascular events in patients with aortic stenosis.
-
We all know that we should be drinking more green tea; every few days, either the media or medical journals are touting a new use for the Asian staple. Can it really cure breast cancer while preventing liver disease, simultaneously increasing knee range of motion in people suffering from osteroarthritis? The answer is "possibly, yes," but an evidence-based review refines the glowing reports with some clinical pearls, dosing specifics, and hopeful avenues of future research, as detailed below.
-
A randomized controlled trial of weekly clinical hypnosis sessions plus home self-hypnosis practice over 5 weeks for breast cancer survivors with hot flashes resulted in significant symptomatic improvement when compared to a matched group of women who received no additional treatment.
-
A prospective, randomized controlled trial measured the impact of a low-fat diet that included high levels of omega-3 fatty acids from fish oil on biomarkers for prostate cancer. No significant differences were found for the primary outcome during an interim analysis and the trial was stopped early. Analysis of secondary endpoints showed some significant differences between the groups, although other biomarkers did not differ.
